{
  "figure_1": "Graphical simplification of cell cycle phases, checkpoints and regulatory mechanisms in breast cancer.",
  "figure_3": "Rationale and challenges for the potential development of cell cycle inhibitors in combination with other therapies in breast cancer. ADC, antibodyâ€“drug conjugate; HRD, homologous recombination deficiency; ICI, immune checkpoint inhibitor; ILD, interstitial lung disease; LFT, liver function tests; TME, tumour microenvironment."
}